DK1017404T3 - Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom - Google Patents

Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom

Info

Publication number
DK1017404T3
DK1017404T3 DK98944115T DK98944115T DK1017404T3 DK 1017404 T3 DK1017404 T3 DK 1017404T3 DK 98944115 T DK98944115 T DK 98944115T DK 98944115 T DK98944115 T DK 98944115T DK 1017404 T3 DK1017404 T3 DK 1017404T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical composition
inflammatory bowel
bowel disease
disease
Prior art date
Application number
DK98944115T
Other languages
English (en)
Inventor
Jean-Pierre Sachetto
William Jeffery Sandborn
William John Tremaine
Original Assignee
Celltech Pharma Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720590.0A external-priority patent/GB9720590D0/en
Priority claimed from GBGB9725346.2A external-priority patent/GB9725346D0/en
Application filed by Celltech Pharma Europ Ltd filed Critical Celltech Pharma Europ Ltd
Application granted granted Critical
Publication of DK1017404T3 publication Critical patent/DK1017404T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/723Xanthans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98944115T 1997-09-26 1998-09-25 Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom DK1017404T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9720590.0A GB9720590D0 (da) 1997-09-26 1997-09-26
GBGB9725346.2A GB9725346D0 (en) 1997-11-28 1997-11-28 Pharmaceutical composition for the treatment of inflammatory bowel disease
PCT/GB1998/002899 WO1999016454A1 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease
EP98944115A EP1017404B1 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
DK1017404T3 true DK1017404T3 (da) 2004-11-01

Family

ID=26312333

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98944115T DK1017404T3 (da) 1997-09-26 1998-09-25 Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom

Country Status (11)

Country Link
US (1) US7341741B1 (da)
EP (1) EP1017404B1 (da)
JP (2) JP4180791B2 (da)
AT (1) ATE269710T1 (da)
AU (1) AU758501B2 (da)
CA (1) CA2304948C (da)
DE (1) DE69824748T2 (da)
DK (1) DK1017404T3 (da)
ES (1) ES2224428T3 (da)
PT (1) PT1017404E (da)
WO (1) WO1999016454A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU638460B2 (en) 1989-04-21 1993-07-01 E.I. Du Pont De Nemours And Company Fungicidal oxazolidinones
US6166024A (en) * 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
DE69834038D1 (de) 1997-07-01 2006-05-18 Isis Pharmaceutical Inc Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre
EP1080103A4 (en) * 1998-05-21 2003-07-02 Isis Pharmaceuticals Inc PREPARATIONS AND METHOD FOR THE NON-PARENTERAL ADMINISTRATION OF OLIGONUCLEOTIDES
IT1301947B1 (it) * 1998-07-28 2000-07-20 Chiesi Farma Spa Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
AUPP915099A0 (en) * 1999-03-12 1999-04-15 Monk, Michael Mendel Improved composition for oral administration
FI119429B (fi) * 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
US8084432B2 (en) * 2003-02-13 2011-12-27 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of pouchitis
EP1820538A4 (en) * 2004-09-07 2012-06-20 Hakuto Kk COSMETICS AND MANUFACTURING METHOD THEREFOR
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
WO2009137672A1 (en) * 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
ES2627745T3 (es) * 2008-11-13 2017-07-31 Nogra Pharma Limited Composiciones antisentido, y procedimientos de fabricación y uso de las mismas
GB0823472D0 (en) * 2008-12-23 2009-01-28 Photocure Asa Product
US9402968B2 (en) 2012-07-11 2016-08-02 Mercy Medical Research Institute, Inc. Colorectal delivery device
WO2014154677A1 (en) * 2013-03-25 2014-10-02 Ferring Bv Composition for the treatment of disease
MX2019012086A (es) 2017-04-14 2021-01-08 Gelesis Llc Composiciones y métodos para tratar o prevenir trastornos relacionados con la permeabilidad intestinal.
EP3986487B1 (en) 2019-06-19 2025-12-17 Inx Medical, LLC Foamable composition for use in surgical diagnostic procedures
EP4058044A4 (en) * 2019-11-11 2023-05-17 Ohio State Innovation Foundation Treatment for inflammatory bowel disease and radiation-induced intestinal injury

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924570A1 (de) 1989-07-25 1991-01-31 Henning Berlin Gmbh Pharmazeutische zubereitung zur rektalen verabreichung
WO1992016214A1 (en) 1991-03-15 1992-10-01 Norwich Eaton Pharmaceuticals Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
DK0586488T3 (da) * 1991-06-07 1995-09-04 Byk Nederland Bv Farmaceutisk klysterpræparat
FR2692484B1 (fr) * 1992-06-22 1995-06-30 Gouchet Franck Nouvelle forme galenique de 4-asa a liberation controlee.
WO1995016451A1 (fr) 1992-06-22 1995-06-22 Franck Arno Gouchet Comprimes a liberation controlee de 4-asa
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
US5691343A (en) * 1995-03-30 1997-11-25 Mayo Foundation For Medical Education And Research Use of topical azathioprine to treat inflammatory bowel disorders
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
SE9602644D0 (sv) 1996-07-04 1996-07-04 Astra Ab New use

Also Published As

Publication number Publication date
JP4180791B2 (ja) 2008-11-12
JP2001517708A (ja) 2001-10-09
ES2224428T3 (es) 2005-03-01
DE69824748D1 (de) 2004-07-29
US7341741B1 (en) 2008-03-11
WO1999016454A1 (en) 1999-04-08
DE69824748T2 (de) 2005-08-25
CA2304948C (en) 2009-12-29
CA2304948A1 (en) 1999-04-08
AU9178098A (en) 1999-04-23
EP1017404A1 (en) 2000-07-12
PT1017404E (pt) 2004-11-30
JP2008143914A (ja) 2008-06-26
AU758501B2 (en) 2003-03-20
EP1017404B1 (en) 2004-06-23
ATE269710T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
DK1017404T3 (da) Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom
TWI256389B (en) Novel hPPAR delta agonists and pharmaceutical compositions comprising the same
NL300389I1 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
DZ2375A1 (fr) Prévention de la perte et restauration de la masseosseuse par certains agonistes des prostaglandine s.
GR3023541T3 (en) N,O-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them
LU91223I2 (fr) Ivabradine et ses dérivés pharmaceutiquement acceptables (procoralan)
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
IL118047A0 (en) Sulfated oligosaccharides pharmaceutical compositions containing them and their use
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
EA200200890A1 (ru) Применение ингибиторов il-18
SE9602442D0 (sv) Administration of pharmaceuticals
DE69033970D1 (de) Huperzin a analoge verbindungen
DK0871434T4 (da) Oralt farmaceutisk sammensætning med modificeret frigivelse indeholdende 5-ASA og fremgangsmåde til behandling af tarmsygdomme
DE69104292D1 (de) Manschettenverbindung und Rohranschlussstück.
ATE203246T1 (de) Dialkyltiacumicine
NO20001909L (no) FremgangsmÕte og anlegg for fremstilling av 1,2-dikloretan
BG102667A (en) Diosgenine-containing composition
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
DE69624308D1 (de) Bernsteinsäurederivate als abbaubare Chelatbildner, ihre Verwendungen und Zusammensetzungen
DE69613395D1 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
FI911365L (fi) En farmaceutisk jodkomposition.
NO913661D0 (no) Anordning og fremgangsmaate for dosering av vaskemiddelkompositter.
FR2684096B1 (fr) Compositions de ciments contenant des cendres volantes.